Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
***** Acces problem to record *****\

Identifieur interne : 000803 ( Pmc/Corpus ); précédent : 0008029; suivant : 0008040 ***** probable Xml problem with record *****

Links to Exploration step


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran</title>
<author>
<name sortKey="Tuite, Ashleigh R" sort="Tuite, Ashleigh R" uniqKey="Tuite A" first="Ashleigh R." last="Tuite">Ashleigh R. Tuite</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bogoch, Isaac I" sort="Bogoch, Isaac I" uniqKey="Bogoch I" first="Isaac I." last="Bogoch">Isaac I. Bogoch</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sherbo, Ryan" sort="Sherbo, Ryan" uniqKey="Sherbo R" first="Ryan" last="Sherbo">Ryan Sherbo</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Watts, Alexander" sort="Watts, Alexander" uniqKey="Watts A" first="Alexander" last="Watts">Alexander Watts</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fisman, David" sort="Fisman, David" uniqKey="Fisman D" first="David" last="Fisman">David Fisman</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Khan, Kamran" sort="Khan, Kamran" uniqKey="Khan K" first="Kamran" last="Khan">Kamran Khan</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">32176272</idno>
<idno type="pmc">7081176</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081176</idno>
<idno type="RBID">PMC:7081176</idno>
<idno type="doi">10.7326/M20-0696</idno>
<date when="2020">2020</date>
<idno type="wicri:Area/Pmc/Corpus">000803</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000803</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran</title>
<author>
<name sortKey="Tuite, Ashleigh R" sort="Tuite, Ashleigh R" uniqKey="Tuite A" first="Ashleigh R." last="Tuite">Ashleigh R. Tuite</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Bogoch, Isaac I" sort="Bogoch, Isaac I" uniqKey="Bogoch I" first="Isaac I." last="Bogoch">Isaac I. Bogoch</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Sherbo, Ryan" sort="Sherbo, Ryan" uniqKey="Sherbo R" first="Ryan" last="Sherbo">Ryan Sherbo</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Watts, Alexander" sort="Watts, Alexander" uniqKey="Watts A" first="Alexander" last="Watts">Alexander Watts</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Fisman, David" sort="Fisman, David" uniqKey="Fisman D" first="David" last="Fisman">David Fisman</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Khan, Kamran" sort="Khan, Kamran" uniqKey="Khan K" first="Kamran" last="Khan">Kamran Khan</name>
<affiliation>
<nlm:aff>NONE</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Annals of Internal Medicine</title>
<idno type="ISSN">0003-4819</idno>
<idno type="eISSN">1539-3704</idno>
<imprint>
<date when="2020">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Ann Intern Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Ann. Intern. Med</journal-id>
<journal-id journal-id-type="publisher-id">aim</journal-id>
<journal-title-group>
<journal-title>Annals of Internal Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">0003-4819</issn>
<issn pub-type="epub">1539-3704</issn>
<publisher>
<publisher-name>American College of Physicians</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32176272</article-id>
<article-id pub-id-type="pmc">7081176</article-id>
<article-id pub-id-type="doi">10.7326/M20-0696</article-id>
<article-id pub-id-type="publisher-id">aim-olf-M200696</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letters: Observations</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tuite</surname>
<given-names>Ashleigh R.</given-names>
</name>
<degrees>PhD, MPH</degrees>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bogoch</surname>
<given-names>Isaac I.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sherbo</surname>
<given-names>Ryan</given-names>
</name>
<degrees>MSc</degrees>
<xref ref-type="aff" rid="aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Watts</surname>
<given-names>Alexander</given-names>
</name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fisman</surname>
<given-names>David</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Kamran</given-names>
</name>
<degrees>MD, MPH</degrees>
<xref ref-type="aff" rid="aff4"></xref>
</contrib>
<aff id="aff1">
<label>1</label>
University of Toronto, Toronto, Ontario, Canada (A.R.T., D.F.)</aff>
<aff id="aff2">
<label>2</label>
University of Toronto and University Health Network, Toronto, Ontario, Canada (I.I.B.)</aff>
<aff id="aff3">
<label>3</label>
St. Michael's Hospital and BlueDot, Toronto, Ontario, Canada (R.S., A.W.)</aff>
<aff id="aff4">
<label>4</label>
University of Toronto, St. Michael's Hospital, and BlueDot, Toronto, Ontario, Canada (K.K.)</aff>
</contrib-group>
<pub-date pub-type="epub">
<day>16</day>
<month>3</month>
<year>2020</year>
</pub-date>
<elocation-id>M20-0696</elocation-id>
<permissions>
<copyright-year>2020</copyright-year>
<copyright-holder>American College of Physicians</copyright-holder>
<license license-type="free">
<license-p>This article is made available via the PMC Open Access Subset for unrestricted re-use for research, analyses, and text and data mining through PubMed Central. Acknowledgement of the original source shall include a notice similar to the following: “© 2020 American College of Physicians. Some rights reserved. This work permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.” These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. </license-p>
</license>
</permissions>
</article-meta>
</front>
<body>
<p>
<italic>Background:</italic>
The coronavirus disease 2019 (COVID-19) epidemic began in Wuhan, China, in late 2019 and continues to spread globally (
<xref rid="r1-0696" ref-type="bibr">1</xref>
), with exported cases confirmed in 109 countries at the time of writing (
<xref rid="r2-0696" ref-type="bibr">2</xref>
). During the interval between 19 February and 23 February 2020, Iran reported its first 43 cases, with 8 deaths. Three exported cases originating in Iran were identified, suggesting an underlying burden of disease in that country greater than that indicated by reported cases. A large epidemic in Iran could further fuel global dissemination of COVID-19.</p>
<p>
<italic>Objective:</italic>
To quantify the COVID-19 outbreak size in Iran on the basis of known exported case counts and air travel links between Iran and other countries, and to anticipate where infections originating in Iran may spread next.</p>
<p>
<italic>Methods:</italic>
We assessed interconnectivity between Iran and other countries by using direct and total traveler volumes and final destination cities of travelers originating in Iran in February 2019, according to data from the International Air Transport Association (accounting for 90% of global air travel, with the other 10% modeled by using market intelligence). Because exported cases were identified in United Arab Emirates (UAE), Lebanon, and Canada, we used the methods of Fraser and colleagues (
<xref rid="r3-0696" ref-type="bibr">3</xref>
) to estimate the size of the underlying epidemic in Iran that would be needed for these cases to be observed with a reasonable probability. To estimate the time at risk for COVID-19 exposure among travelers departing Iran, we obtained data from the United Nations World Tourism Organization for the proportion of international travelers who are residents of Iran (
<xref rid="r4-0696" ref-type="bibr">4</xref>
) and the average length of stay of tourists to Iran (
<xref rid="r5-0696" ref-type="bibr">5</xref>
), and assumed that the Iranian outbreak began in early January 2020. We evaluated the relationship between the strength of travel links with Iran and the ranking of destination countries on the Infectious Disease Vulnerability Index (IDVI), a validated metric that estimates the capacity of a country to respond to an infectious disease outbreak. Scores range from 0 to 1, with higher scores reflecting greater capacity to manage infectious outbreaks.</p>
<p>
<italic>Findings:</italic>
A total of 212 000 persons traveled from Iranian airports (Tehran, Rasht, and Arak) to international destinations in February 2019. Although Qom has reported COVID-19 cases, its international airport is still under construction. Global cities receiving the greatest number of total travelers from Iran during this period include Istanbul, Turkey (
<italic>n</italic>
 = 46 550); Najaf, Iraq (
<italic>n</italic>
 = 24 659); and Dubai, UAE (
<italic>n</italic>
 = 16 340). Among the top 10 traveler-receiving cities, 4 (Najaf, Baghdad, Damascus, and Baku) are in countries with an IDVI score lower than 0.6, suggesting elevated vulnerability to infectious disease outbreaks as well as limited ability to detect cases (
<xref ref-type="fig" rid="f1-0696">Figure 1</xref>
).</p>
<fig id="f1-0696" orientation="portrait" position="float">
<label>Figure 1.</label>
<caption>
<p>
<bold>Top 20 international cities connected to Iran by commercial air travel and associated vulnerability to infectious disease outbreaks.</bold>
</p>
<p>Vulnerability is measured at the country level by using the IDVI score, with a lower value indicating reduced capacity to respond to outbreaks. Countries with the lowest IDVI scores are indicated in green. The top 20 cities accounted for 70% of international outbound traveler volumes from Iran in February 2019. The first and 20th ranked cities, Istanbul and Milan, had 46 550 and 2500 outbound passengers, respectively, during this period. IDVI = Infectious Disease Vulnerability Index.</p>
</caption>
<graphic xlink:href="aim-olf-M200696-M200696ff1"></graphic>
</fig>
<p>United Arab Emirates, Lebanon, and Canada ranked third, 21st, and 31st, respectively, for outbound air travel volume from Iran in February 2019. We estimated that 18 300 COVID-19 cases (95% CI, 3770 to 53 470 cases) would have had to occur in Iran, assuming an outbreak duration of 1.5 months in the country, in order to observe these 3 internationally exported cases reported at the time of writing.</p>
<p>Given the low rankings for Lebanon and Canada for outbound air travel, it is unlikely that cases would be identified in these countries and not in Iraq, Syria, or Azerbaijan (countries with higher travel volumes but low IDVI scores). Considering traveler volume alone, the odds of a single case being imported into Iraq rather than Canada or Lebanon would be 33.6 to 1 and 15.4 to 1 respectively; for Azerbaijan, the odds would be 3.8 to 1 and 1.7 to 1, respectively; and for Syria, the odds would be 3.7 to 1 and 1.7 to 1, respectively. As such, we performed exploratory analyses in which we assumed that an unidentified exported case of COVID-19 was present in Iraq, Syria, Azerbaijan, or all 3 countries, in addition to Lebanon, Canada, and UAE, and estimated the outbreak size in Iran that would produce these results (
<xref ref-type="fig" rid="f2-0696">Figure 2</xref>
). We also evaluated a scenario in which we assumed perfect case detection in travelers from Iran, such that disease is truly absent in countries not reporting cases. Under this “best-case” scenario, the estimated outbreak size in Iran was smaller but still substantial (1820 cases [CI, 380 to 5320 cases]).</p>
<fig id="f2-0696" orientation="portrait" position="float">
<label>Figure 2.</label>
<caption>
<p>
<bold>Estimated outbreak size in Iran required to observe exported cases internationally.</bold>
</p>
<p>The estimated cumulative number of COVID-19 cases in Iran required to observe 3 cases exported to UAE, LBN, and CAN is shown in green. We also estimated the outbreak size required under alternate scenarios, including no additional exported cases to any other international destinations despite perfect case detection and 1 additional exported case to IRQ, AZE, or SYR (independently or to all 3 countries). Mean and 95% CIs are presented. The rate at which persons become infected while in Iran was assumed to be the same for residents and visitors. The rate of infection among air passengers (λ) was estimated as number of exported cases ÷ person-time at risk while in Iran. Person-time at risk was calculated as number of outbound air passengers × (average length of stay for visitors × proportion of air passengers who are visitors + outbreak duration × proportion of air passengers who are residents of Iran). Outbreak size in Iran was then estimated as λ × population size of Iran × outbreak duration. AZE = Azerbaijan; CAN = Canada; COVID-19 = coronavirus disease 2019; IRQ = Iraq; LBN = Lebanon; SYR = Syria; UAE = United Arab Emirates.</p>
</caption>
<graphic xlink:href="aim-olf-M200696-M200696ff2"></graphic>
</fig>
<p>
<italic>Discussion:</italic>
Given the low volumes of air travel to countries with identified cases of COVID-19 originating in Iran (such as Canada), Iran probably is currently experiencing a COVID-19 epidemic of substantial size for such exportations to be occurring. Our analysis would be modified by travel restrictions from Iran due to the recent political situation and by variations in the R
<sub>0</sub>
value. Further, the lack of identified COVID-19 cases in countries with far closer travel ties to Iran suggests that cases in these countries are probably being missed rather than being truly absent. This is concerning, both for public health in Iran itself and because of the high likelihood for outward dissemination of the disease to neighboring countries with lower capacity to respond to infectious disease epidemics. Supporting capacity for public health initiatives in the region is urgently needed.</p>
<sec>
<title></title>
</sec>
</body>
<back>
<fn-group>
<fn id="n0-M200696">
<p>This article was published at Annals.org on 16 March 2020.</p>
</fn>
</fn-group>
<bio id="d35e92">
<p>
<bold>Note:</bold>
Drs. Tuite and Bogoch contributed equally to this work.</p>
<p>
<bold>Grant Support:</bold>
By grant 02179-000 from the Canadian Institutes of Health Research.</p>
<p>
<bold>Disclosures:</bold>
Disclosures can be viewed at
<uri xlink:type="simple" xlink:href="http://www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-0696">www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M20-0696</uri>
.</p>
<p>
<bold>Reproducible Research Statement: </bold>
<italic>Study protocol:</italic>
Not applicable.
<italic>Statistical code:</italic>
Available from Dr. Tuite (
<uri xlink:type="simple" xlink:href="ashleigh.tuite@utoronto.ca">ashleigh.tuite@utoronto.ca</uri>
).
<italic>Data set:</italic>
Available from Dr. Khan (
<uri xlink:type="simple" xlink:href="kamran.khan@unityhealth.to">kamran.khan@unityhealth.to</uri>
).</p>
<p>
<bold>Previous Posting:</bold>
This manuscript was posted as a preprint on medRxiv on 25 February 2020. doi:10.1101/2020.02.24.20027375</p>
</bio>
<ref-list>
<title>References</title>
<ref id="r1-0696">
<label>Bogoch II, Watts A, Thomas-Bachli A, et al.</label>
<mixed-citation publication-type="unrecognized">
<comment>
<bold>Bogoch II, Watts A, Thomas-Bachli A, et al.</bold>
Potential for global spread of a novel coronavirus from China. J Travel Med. 2020. [PMID: 31985790] doi:10.1093/jtm/taaa011</comment>
</mixed-citation>
</ref>
<ref id="r2-0696">
<label>World Health Organization.</label>
<mixed-citation publication-type="unrecognized">
<comment>
<bold>World Health Organization.</bold>
Coronavirus disease 2019 (COVID-19) situation report – 33. Accessed at
<uri xlink:type="simple" xlink:href="http://www.who.int/docs/default-source/coronaviruse/situation-reports/20200222-sitrep-33-covid-19.pdf?sfvrsn=c9585c8f_2">www.who.int/docs/default-source/coronaviruse/situation-reports/20200222-sitrep-33-covid-19.pdf?sfvrsn=c9585c8f_2</uri>
on 22 February 2020.</comment>
</mixed-citation>
</ref>
<ref id="r3-0696">
<label>Fraser C, Donnelly CA, Cauchemez S, et al; WHO Rapid Pandemic Assessment Collaboration.</label>
<mixed-citation publication-type="unrecognized">
<comment>
<bold>Fraser C, Donnelly CA, Cauchemez S, et al; WHO Rapid Pandemic Assessment Collaboration.</bold>
Pandemic potential of a strain of influenza A (H1N1): early findings. Science. 2009;324:1557-61. [PMID: 19433588] doi:10.1126/science.1176062</comment>
</mixed-citation>
</ref>
<ref id="r4-0696">
<label>United Nations World Tourism Organization.</label>
<mixed-citation publication-type="unrecognized">
<comment>
<bold>United Nations World Tourism Organization.</bold>
Tourism Statistics: Iran, Islamic Republic Of: Country-specific: Basic indicators (Compendium) 2014–2018. Accessed at
<uri xlink:type="simple" xlink:href="http://www.e-unwto.org/doi/abs/10.5555/unwtotfb0364010020142018201912">www.e-unwto.org/doi/abs/10.5555/unwtotfb0364010020142018201912</uri>
on 22 February 2020.</comment>
</mixed-citation>
</ref>
<ref id="r5-0696">
<label>United Nations.</label>
<mixed-citation publication-type="unrecognized">
<comment>
<bold>United Nations.</bold>
Encyclopedia of the Nations: Average length of stay of visitors - Tourism indicators - UNCTAD Handbook of Statistics - Country Comparison. Accessed at
<uri xlink:type="simple" xlink:href="http://www.nationsencyclopedia.com/WorldStats/UNCTAD-average-length-stay-visitors.html">www.nationsencyclopedia.com/WorldStats/UNCTAD-average-length-stay-visitors.html</uri>
on 22 February 2020.</comment>
</mixed-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000803  | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000803  | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     
   |texte=   
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021